B. Gautret

Multiple sites for the cardiovascular actions of fentanyl in rats.

H. Schmitt, B. Gautret, 1985 .

Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.

C. Cazaubon, C. Lacour, P. Guiraudou, 1993, The Journal of pharmacology and experimental therapeutics.

Central α1-adrenergic and opiate systems in the control of the vagal tone in normotensive and spontaneously hypertensive rats

H. Schmitt, F. Huguet, A. Huchet, 1986 .

Central and peripheral sites for cardiovascular actions of dynorphin-(1-13) in rats.

H. Schmitt, B. Gautret, 1985, European journal of pharmacology.

Vagally mediated reflex and cardiac slowing induced by loperamide in rats.

H. Schmitt, B. Gautret, 1985, European journal of pharmacology.

Cardiac slowing induced by peripheral κ-opiate receptor stimulation in rats

H. Schmitt, B. Gautret, 1984 .

Cardiac slowing induced by peripheral kappa-opiate receptor stimulation in rats.

H. Schmitt, B. Gautret, 1984, European journal of pharmacology.

FURTHER INVESTIGATIONS ON THE α1‐ADRENOCEPTOR BLOCKING PROPERTIES OF AR‐C 239 IN RATS

M. Andréjak, H. Schmitt, M. Doursout, 1985 .

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

J. Simiand, P. Soubrié, M. Rinaldi-Carmona, 1992, The Journal of pharmacology and experimental therapeutics.